Pricing Log in Create free account

Freenome, Inc (FRNM) vs Personalis, Inc. (PSNL)

Freenome, Inc and Personalis, Inc. are both Diagnostics & Research companies. Personalis, Inc. is the larger, with a market value of $1.7B against $1.1B — 1.5× the size. Freenome, Inc has the higher net margin (0.00% vs −147.7%) and the higher return on invested capital (0.00% vs −358.4%). Across the 11 metrics below, Freenome, Inc leads on 9 and Personalis, Inc. on 2.

Valuation

Metric FRNM PSNL Diagnostics & Research median
P/E n/m n/m 34.52
P/S n/m 20.71 4.24
P/B n/m 7.86 3.42
Price to free cash flow n/m n/m 33.51
EV/EBITDA n/m n/m 23.44
EV/Sales n/m 18.57 5.18
Earnings yield (2.98%) (7.50%) (1.50%)
Free cash flow yield (3.55%) (6.35%) 0.00%

Profitability

Metric FRNM PSNL Diagnostics & Research median
Gross margin — 16.71% 48.32%
Operating margin 0.00% (156.66%) (5.68%)
Net margin 0.00% (147.74%) (4.10%)
Free cash flow margin 0.00% (120.79%) 0.00%
Return on equity 17.81% (62.14%) 0.00%
Return on assets (0.86%) (44.66%) (6.05%)
Return on invested capital 0.00% (358.37%) 0.00%

Growth

Metric FRNM PSNL Diagnostics & Research median
Revenue growth (TTM) — 16.88% 8.99%
EPS growth (last fiscal year) (58.34%) 33.58% 20.36%
Revenue growth, 5-year CAGR — (2.40%) 7.30%
Net income growth, 5-year CAGR — 0.00% 0.00%

Health

Metric FRNM PSNL Diagnostics & Research median
Debt to equity 0.00 0.00 0.01
Current ratio 0.20 4.53 2.27
Net debt to EBITDA 0.29 2.93 0.68

Dividend

Metric FRNM PSNL Diagnostics & Research median
Dividend yield — — 0.67%
Payout ratio — — 0.20

Size

Metric FRNM PSNL Diagnostics & Research median
Market cap 1.12b 1.69b 2.22b

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack